Abiopharma

🔍 Chen Kerry Xuefeng (Executive)

Company: ATRenew Inc. (RERE)

Report Date: 2026-03-25

Detailed Transactions and Holdings:

• Acquired 8,423,097 shares of American depositary shares (Direct)
  Date: 2026-03-25 | Code: M | equity_swap_involved: false | shares_owned_after: 9,134,518.00 | transaction_form_type: 4 | Footnotes: F1, F1
• Holds 0 shares of Class C ordinary shares (Direct)
  Date: 2026-03-25 | Code: H | nature_of_ownership: By C&XF Group Limited | shares_owned_after: 11,287,336.00 | Footnotes: F2
• Sold 407,200 shares of Options (Right to Buy) at $0.1 per share (Derivative)
  Date: 2026-03-25 | Code: M | Expires: 2027-01-01 | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F3
• Sold 19,844 shares of Options (Right to Buy) at $0.1 per share (Derivative)
  Date: 2026-03-25 | Code: M | Expires: 2028-07-01 | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F4
• Sold 15,314 shares of Options (Right to Buy) at $0.1 per share (Derivative)
  Date: 2026-03-25 | Code: M | Expires: 2029-01-01 | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F5
• Sold 75,931 shares of Options (Right to Buy) at $0.1 per share (Derivative)
  Date: 2026-03-25 | Code: M | Expires: 2029-01-01 | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F6
• Sold 26,521 shares of Options (Right to Buy) at $0.1 per share (Derivative)
  Date: 2026-03-25 | Code: M | Expires: 2026-09-01 | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F7
• Sold 4,793 shares of Options (Right to Buy) at $0.1 per share (Derivative)
  Date: 2026-03-25 | Code: M | Expires: 2026-10-04 | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F8
• Sold 70,650 shares of Options (Right to Buy) at $0.1 per share (Derivative)
  Date: 2026-03-25 | Code: M | Expires: 2029-07-31 | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F9
• Sold 64,291 shares of Options (Right to Buy) at $0.1 per share (Derivative)
  Date: 2026-03-25 | Code: M | Expires: 2031-01-01 | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F10
• Sold 1,725,746 shares of Options (Right to Buy) at $0.1 per share (Derivative)
  Date: 2026-03-25 | Code: M | Expires: 2031-01-01 | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F11
• Sold 2,964,091 shares of Restricted share units (Derivative)
  Date: 2026-03-25 | Code: M | Expires: 2031-04-13 | Exercise: 2021-04-13 | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F12
• Sold 179,030 shares of Options (Right to Buy) at $0.1 per share (Derivative)
  Date: 2026-03-25 | Code: M | Expires: 2032-01-01 | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F13
• Sold 1,378 shares of Options (Right to Buy) at $0.1 per share (Derivative)
  Date: 2026-03-25 | Code: M | Expires: 2033-03-13 | Exercise: 2024-03-13 | equity_swap_involved: false | transaction_form_type: 4
• Sold 7,276 shares of Options (Right to Buy) at $0.1 per share (Derivative)
  Date: 2026-03-25 | Code: M | Expires: 2033-04-01 | Exercise: 2024-04-01 | equity_swap_involved: false | transaction_form_type: 4
• Sold 53,333 shares of Options (Right to Buy) at $0.1 per share (Derivative)
  Date: 2026-03-25 | Code: M | Expires: 2035-07-01 | Exercise: 2025-07-01 | equity_swap_involved: false | transaction_form_type: 4

Footnotes:

• F1: Represents American depositary shares acquired through the exercise of options and the vesting of restricted share units. Every three American depositary shares ("ADS") represent two Class A ordinary shares, par value US$0.001 per share.
• F2: Shares held of record by C&XF Group Limited, which is wholly owned by the reporting person.
• F3: Represents options to purchase 407,200 Class A ordinary shares granted on January 1, 2017. The options vest in equal installments of 1/4 of the options on the January 1 of each year thereafter over the next 4 years, subject to the reporting person's continued service through the applicable vesting date.
• F4: Represents options to purchase 19,844 Class A ordinary shares granted on July 1, 2018. The options vest in equal installments of 1/4 of the options on the July 1 of each year thereafter over the next 4 years, subject to the reporting person's continued service through the applicable vesting date.
• F5: Represents options to purchase 15,314 Class A ordinary shares granted on January 1, 2019. The options vest in equal installments of 1/4 of the options on the January 1 of each year thereafter over the next 4 years, subject to the reporting person's continued service through the applicable vesting date.
• F6: Represents options to purchase 75,931 Class A ordinary shares granted on January 1, 2019. The options vest in equal installments of 1/4 of the options on the January 1 of each year thereafter over the next 4 years, subject to the reporting person's continued service through the applicable vesting date.
• F7: Represents options to purchase 26,521 Class A ordinary shares granted on September 1, 2016. The options vest in equal installments of 1/4 of the options on the September 1 of each year thereafter over the next 4 years, subject to the reporting person's continued service through the applicable vesting date.
• F8: Represents options to purchase 4,793 Class A ordinary shares granted on October 4, 2016. The options vest in equal installments of 1/4 of the options on the October 4 of each year thereafter over the next 4 years, subject to the reporting person's continued service through the applicable vesting date.
• F9: Represents options to purchase 70,650 Class A ordinary shares granted on July 31, 2019. The options vest in equal installments of 1/4 of the options on the July 31 of each year thereafter over the next 4 years, subject to the reporting person's continued service through the applicable vesting date.
• F10: Represents options to purchase 64,291 Class A ordinary shares granted on January 1, 2021. The options vest in equal installments of 1/4 of the options on the January 1 of each year thereafter over the next 4 years, subject to the reporting person's continued service through the applicable vesting date.
• F11: Represents options to purchase 1,725,746 Class A ordinary shares granted on January 1, 2021. The options vest in equal installments of 1/4 of the options on the January 1 of each year thereafter over the next 4 years, subject to the reporting person's continued service through the applicable vesting date.
• F12: Each restricted share unit represents the contingent right to receive one (1) Class A ordinary shares of the Issuer upon vesting.
• F13: Represents options to purchase 179,030 Class A ordinary shares granted on January 1, 2022. The options vest in equal installments of 1/4 of the options on the January 1 of each year thereafter over the next 4 years, subject to the reporting person's continued service through the applicable vesting date.